{{Rsnum
|rsid=932206
|Chromosome=2
|position=136067702
|Orientation=plus
|GMAF=0.2006
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 38.9 | 44.2 | 16.8
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 0.0 | 0.0 | 100.0
| ASW | 3.5 | 17.5 | 78.9
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 3.0 | 26.7 | 70.3
| LWK | 0.0 | 0.0 | 0.0
| MEX | 12.1 | 29.3 | 58.6
| MKK | 0.0 | 0.0 | 0.0
| TSI | 2.9 | 15.7 | 81.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=22052079
|Title=Association analysis of 31 common polymorphisms with type 2 diabetes and its related traits in Indian sib pairs
|OA=1
}}

{{PMID|18461161|OA=1
}} Post genome-wide association studies of novel genes associated with type 2 diabetes show gene-gene interaction and high predictive value.

{{PMID|18463370|OA=1
}} Chromosome 6p22 locus associated with clinically aggressive neuroblastoma.

{{PMID|21278902|OA=1
}} Genetic risk profiling for prediction of type 2 diabetes.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}